The effects of continuous treatment of stallions with high levels of a potent GnRH analogue.

This study evaluates the impact of prolonged exposure to a potent version of Gonadotropin-releasing hormone (GnRH) on stallions. In all experimental rounds, both short-term and long-term, the treatment led to an initial surge in hormone levels (FSH, LH, and testosterone), followed by reduction, but did not significantly affect libido nor other seminal characteristics in the animals.

Experiment Design and Procedure

• In this study, researchers divided nine sexually mature pony stallions into three groups and provided differing doses of Buserelin, a potent analogue of Gonadotropin-Releasing Hormone (GnRH). They administered 240 micrograms, 60 micrograms, or 30-50 micrograms Buserelin daily.
• The administration method included subcutaneously injected slow-release implants and osmotic pumps. Researchers collected frequent blood plasma and serum samples during this period.
• Treatment caused an initial surge in the hormone levels (FSH, LH, and testosterone) in all groups after the insertion of pumps or implants. However, these hormone levels returned to pre-treatment or lower values between 3 to 10 days in most stallions.
• A subsequent experiment involved injecting single implants designed to deliver 120 micrograms Buserelin per day for 28 days into two stallions at intervals of five days. As with the initial experiment, hormone levels spiked in response to the first implant but returned to pre-treatment levels after this and showed no further stimulation with subsequent implants.
• A final long-term experiment sought to establish the effects of chronic treatment with Buserelin on libido and spermatogenesis. Three fertile pony stallions received Buserelin implants at 2- to 5-week intervals for a year while three other stallions acted as controls. Blood tests and semen assessments were made throughout this experiment.

Results and Conclusions

• Gonadotrophin, testosterone, and oestrone sulphate levels were lower in the group treated with Buserelin compared to either pre-treatment or control values.
• Daily sperm output (DSO) was found to be reduced by at least 50% during the treatment period in treated stallions but was seen to have returned to pre-treatment values seven months after the final implant.
• Moreover, no significant effects on other semen characteristics were noted, implying a lack of substantial negative impacts on seminal quality.
• Additionally, there were no observable changes in the libido of the treated subjects over the course of the experiment, suggesting that long-term GnRH administration does not negatively impact stallion libido.

In summary, this study indicates that prolonged exposure to a potent version of Gonadotropin-releasing hormone (GnRH) on stallions initially boosts hormone levels, but these drop off while libido remains unaffected. It provides important insight into the potential use and implications of hormone-altering treatments in horse breeding and management.